- Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Behavioral: IBBS
Sponsors: Yale University; Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Hamden Public Schools, Hamden, CT; C8Sciences; PAXIS Institute; BeCaid, Beijing, China; Peking University, Beijing, China; Capital Medical University, Beijing, China; Beijing Physical Education & Skill College, Beijing, China
Recruiting - verified March 2012 - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Placebo; Drug: RIT124D; Drug: RIT124D; Drug: RIT124D
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Atomoxetine Hydrochloride
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012
 |
Join Clinical Trials in Arizona for ADD/ADHD |
